The Asia Pacific Blood Plasma Derivatives Market would witness market growth of 9.7% CAGR during the forecast period (2022-2028).
More than 100 distinct proteins are present in plasma, including albumin, immunoglobulins, fibrinogen, protease inhibitors, and coagulation factors. Plasma serves a crucial function in controlling blood pressure and transferring essential minerals, such as salt and potassium, to maintain the body's normal pH balance. It is produced by removing suspended cells and proteins. Plasma derivatives include unique plasma protein concentrates derived from blood plasma. These are obtained by the fractionation process.
Albumin, factor VIII and factor IX, immunoglobulins, and anti-inhibitor coagulation complex (AICC), including alpha 1-proteinase inhibitor concentrate, Rh immune globulin, and anti-thrombin III concentrate are plasma derivatives. Albumin is the most abundant and essential component of plasma protein, which is responsible for regulating the oncotic pressure in blood arteries and performing multiple transport tasks. Immunoglobulins are essential for eliciting an effective immune response to a pathogen or infectious illness. Factors VIII and IX are blood clotting factors that contribute to blood coagulation.
Immunoglobulin is primarily responsible for maintaining the osmotic pressure within blood vessels. Immunoglobulin is accountable for the development of immunity in response to the introduction of any foreign particle into the body. The increase in the frequency of life-threatening conditions, such as immunodeficiency, the increase in the geriatric population, and the increase in the use of blood plasma derivatives products are anticipated to drive the blood plasma market.
The expansion of the regional market is attributed to initiatives and authorizations by the governments throughout the region in order to export items, such as bovine protein and serum. According to the World Health Organization's 2011 Census, India is home to 104 million senior citizens or 8.6% of the total population. Women outnumber men among people aged 60 and older. Moreover, life expectancy is rising dramatically, resulting in a rise in the elderly population in the region. This rise in the geriatric population within the region is rapidly augmenting the growth of the regional blood plasma derivatives market.
The China market dominated the Asia Pacific Blood Plasma Derivatives Market by Country in 2021; thereby, achieving a market value of $5,665.4 Million by 2028. The Japan market is poised to grow at a CAGR of 9% during (2022 - 2028). Additionally, The India market would obtain a CAGR of 10.4% during (2022 - 2028).
Based on Application, the market is segmented into Immunodeficiency Diseases, Hypogammaglobulinemia, Hemophilia, Von Willebrand's Disease, and Others. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Blood Plasma Derivatives Market is Projected to reach USD 72.5 Billion by 2028, at a CAGR of 9.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Biotest AG, LFB S.A., CSL Limited, Octapharma AG, Kedrion S.p.A, Sanofi S.A. and Fusion Health Care Pvt. Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Immunodeficiency Diseases
- Hypogammaglobulinemia
- Hemophilia
- Von Willebrand's Disease
- Others
By End User
By Type
- Immunoglobulin
- Albumin
- Factor VIII
- Factor IX
- Hyperimmune Globulin
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Bayer AG
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Biotest AG
- LFB S.A.
- CSL Limited
- Octapharma AG
- Kedrion S.p.A
- Sanofi S.A.
- Fusion Health Care Pvt. Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Blood Plasma Derivatives Market, by Application
1.4.2 Asia Pacific Blood Plasma Derivatives Market, by End User
1.4.3 Asia Pacific Blood Plasma Derivatives Market, by Type
1.4.4 Asia Pacific Blood Plasma Derivatives Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Blood Plasma Derivatives Market
Chapter 4. Asia Pacific Blood Plasma Derivatives Market by Application
4.1 Asia Pacific Immunodeficiency Diseases Market by Country
4.2 Asia Pacific Hypogammaglobulinemia Market by Country
4.3 Asia Pacific Hemophilia Market by Country
4.4 Asia Pacific Von Willebrand's Disease Market by Country
4.5 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Blood Plasma Derivatives Market by End User
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Clinics Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Blood Plasma Derivatives Market by Type
6.1 Asia Pacific Immunoglobulin Market by Country
6.2 Asia Pacific Albumin Market by Country
6.3 Asia Pacific Factor VIII Market by Country
6.4 Asia Pacific Factor IX Market by Country
6.5 Asia Pacific Hyperimmune Globulin Market by Country
6.6 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Blood Plasma Derivatives Market by Country
7.1 China Blood Plasma Derivatives Market
7.1.1 China Blood Plasma Derivatives Market by Application
7.1.2 China Blood Plasma Derivatives Market by End User
7.1.3 China Blood Plasma Derivatives Market by Type
7.2 Japan Blood Plasma Derivatives Market
7.2.1 Japan Blood Plasma Derivatives Market by Application
7.2.2 Japan Blood Plasma Derivatives Market by End User
7.2.3 Japan Blood Plasma Derivatives Market by Type
7.3 India Blood Plasma Derivatives Market
7.3.1 India Blood Plasma Derivatives Market by Application
7.3.2 India Blood Plasma Derivatives Market by End User
7.3.3 India Blood Plasma Derivatives Market by Type
7.4 South Korea Blood Plasma Derivatives Market
7.4.1 South Korea Blood Plasma Derivatives Market by Application
7.4.2 South Korea Blood Plasma Derivatives Market by End User
7.4.3 South Korea Blood Plasma Derivatives Market by Type
7.5 Singapore Blood Plasma Derivatives Market
7.5.1 Singapore Blood Plasma Derivatives Market by Application
7.5.2 Singapore Blood Plasma Derivatives Market by End User
7.5.3 Singapore Blood Plasma Derivatives Market by Type
7.6 Malaysia Blood Plasma Derivatives Market
7.6.1 Malaysia Blood Plasma Derivatives Market by Application
7.6.2 Malaysia Blood Plasma Derivatives Market by End User
7.6.3 Malaysia Blood Plasma Derivatives Market by Type
7.7 Rest of Asia Pacific Blood Plasma Derivatives Market
7.7.1 Rest of Asia Pacific Blood Plasma Derivatives Market by Application
7.7.2 Rest of Asia Pacific Blood Plasma Derivatives Market by End User
7.7.3 Rest of Asia Pacific Blood Plasma Derivatives Market by Type
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Grifols, S.A
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Biotest AG (Tiancheng International Investment Limited)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 LFB S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 CSL Limited (CSL Behring)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Octapharma AG
8.7.1 Company Overview
8.8 Kedrion S.p.A
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fusion Health Care Pvt. Ltd.
8.10.1 Company Overview
TABLE 1 Asia Pacific Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Von Willebrand's Disease Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Von Willebrand's Disease Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Clinics Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Clinics Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Albumin Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Albumin Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Factor VIII Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Factor VIII Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Factor IX Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Factor IX Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Hyperimmune Globulin Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Hyperimmune Globulin Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Blood Plasma Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Blood Plasma Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 39 China Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 40 China Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 41 China Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 42 China Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 43 China Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 44 China Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 45 China Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 46 China Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 47 Japan Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 48 Japan Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 49 Japan Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 50 Japan Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 51 Japan Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 52 Japan Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 53 Japan Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 54 Japan Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 55 India Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 56 India Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 57 India Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 58 India Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 59 India Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 60 India Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 61 India Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 62 India Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 63 South Korea Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 64 South Korea Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 65 South Korea Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 66 South Korea Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 67 South Korea Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 68 South Korea Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 69 South Korea Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 70 South Korea Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 71 Singapore Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 72 Singapore Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 73 Singapore Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 74 Singapore Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 75 Singapore Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 76 Singapore Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 77 Singapore Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 78 Singapore Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 79 Malaysia Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 80 Malaysia Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 81 Malaysia Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 82 Malaysia Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 83 Malaysia Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 84 Malaysia Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 85 Malaysia Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 86 Malaysia Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 87 Rest of Asia Pacific Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 88 Rest of Asia Pacific Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 89 Rest of Asia Pacific Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 90 Rest of Asia Pacific Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 91 Rest of Asia Pacific Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 92 Rest of Asia Pacific Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 93 Rest of Asia Pacific Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 94 Rest of Asia Pacific Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 95 Key Information – Bayer AG
TABLE 96 Key Information – Takeda Pharmaceutical Company Limited
TABLE 97 Key information – Grifols, S.A.
TABLE 98 key information – Biotest AG
TABLE 99 Key Information – LFB S.A
TABLE 100 key Information – CSL Limited
TABLE 101 Key Information – Octapharma AG
TABLE 102 key Information – Kedrion S.p.A
TABLE 103 Key Information – Sanofi S.A.
TABLE 104 Key Information – Fusion Health Care Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Grifols, S.A.
FIG 3 Recent strategies and developments: Kedrion S.p.A